Riten Kumar: Diagnosis and Management of Post-Thrombotic Sequelae Following Non-Extremity VTE in Children
Riten Kumar, Director of Thrombosis and Anticoagulation at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, shared a post on LinkedIn, about a recent article he and his colleagues co-authored, adding:
“Non-extremity thrombosis constitutes approximately 40% of pediatric VTE and is associated with significant long-term morbidity.
In this JTH review, we summarize the current evidence on the epidemiology, pathophysiology, and management of post-thrombotic sequelae following non-extremity VTE in children.”
Title: Non-Extremity Thrombosis Sequelae in Children: Screening, Diagnosis, and Management
Authors: Riten Kumar, Vilmarie Rodriguez, Clay Cohen, Madhvi Rajpurkar, Ayesha Zia
Read the Full Article on JTH
Find more posts featuring Riten Kumar on Hemostasis Today.
-
Sep 10, 2026, 11:56William Pao: Celebrating a Landmark Breakthrough in Hemophilia Care
-
Sep 10, 2026, 11:25Andreas Glenthøj: New Sickle Cell Trait Data in UpToDate
-
Sep 10, 2026, 10:53A New Era of Hemophilia Screening and Diagnosis in Women and Girls – ISTH
-
Sep 10, 2026, 10:03Investing in Youth, Transforming Hemophilia Care – WFH
-
Sep 10, 2026, 09:51Ronke Oke BEM: 20 Years of Newborn Sickle Cell Screening in England
-
Sep 10, 2026, 09:41Seunghwan Song: Hemlibra and the Science That Changed Hemophilia A Care
-
Sep 10, 2026, 09:20Mark Dawson: A Radical Rethink of Hemophilia Treatment
-
Sep 10, 2026, 07:26Carly Newton: Every Donation Helps Save Lives
-
Sep 10, 2026, 07:152023 ACR/EULAR APS Classification Criteria – APS Foundation of America